Torsemide

Generic name: Pronounced as (tore' se mide)
Brand names
  • Demadex®
Click on drug name to hear pronunciation

Medical Content Reviewed By HelloPharmacist Staff

Last Revised - 01/15/2018

Torsemide is used alone or in combination with other medications to treat high blood pressure. Torsemide is used to treat edema (fluid retention; excess fluid held in body tissues) caused by various medical problems, including heart, kidney, or liver disease. Torsemide is in a class of medications called diuretics ('water pills'). It works by causing the kidneys to get rid of unneeded water and salt from the body into the urine.

High blood pressure is a common condition, and when not treated it can cause damage to the brain, heart, blood vessels, kidneys and other parts of the body. Damage to these organs may cause heart disease, a heart attack, heart failure, stroke, kidney failure, loss of vision, and other problems. In addition to taking medication, making lifestyle changes will also help to control your blood pressure. These changes include eating a diet that is low in fat and salt, maintaining a healthy weight, exercising at least 30 minutes most days, not smoking, and using alcohol in moderation.

Torsemide comes as a tablet to take by mouth. It usually is taken once a day. To help you remember to take torsemide, take it around the same time every day. Follow the directions on your prescription label carefully, and ask your doctor or pharmacist to explain any part you do not understand. Take torsemide exactly as directed. Do not take more or less of it or take it more often than prescribed by your doctor.

Torsemide controls high blood pressure and edema but does not cure these conditions. Continue to take torsemide even if you feel well. Do not stop taking torsemide without talking to your doctor.

This medicine is sometimes prescribed for other uses; ask your doctor or pharmacist for more information.

Before taking torsemide,

  • tell your doctor and pharmacist if you are allergic to torsemide, sulfonamide medications, any other medications, or any of the ingredients in torsemide tablets. Ask your pharmacist or check the patient information for a list of the ingredients.

  • tell your doctor and pharmacist what prescription and nonprescription medications, vitamins, nutritional supplements, and herbal products you are taking or plan to take. Be sure to mention any of the following: aminoglycoside antibiotics such as amikacin, gentamicin (Garamycin), or tobramycin (Bethkis, Tobi), aspirin and nonsteroidal anti-inflammatory drugs (NSAIDs) such as ibuprofen (Advil, Motrin, others) and naproxen (Aleve, Naprosyn, others); corticosteroids such as betamethasone (Celestone), budesonide (Entocort), cortisone (Cortone), dexamethasone (Decadron, Dexpak, Dexasone, others), fludrocortisone (Floriner), hydrocortisone (Cortef, Hydrocortone), methylprednisolone (Medrol, Meprolone, others), prednisolone (Prelone, others), prednisone (Rayos), and triamcinolone (Aristocort, Azmacort); corticotropin (ACTH, H.P., Acthar Gel); digoxin (Lanoxin), ethacrynic acid (Edecrin), indomethacin (Indocin), lithium (Lithobid), medications for high blood pressure or pain, and probenecid (Probalan, Probenemid). Your doctor may need to change the doses of your medications or monitor you carefully for side effects.

  • if you are taking cholestyramine (Questran), take it 4 hours before or 1 hour after toresemide.

  • tell your doctor if you have or have ever had kidney disease. Your doctor may tell you not to take toresemide.

  • tell your doctor if you have or have ever had diabetes, gout, heart, or liver disease.

  • tell your doctor if you are pregnant, plan to become pregnant, or are breastfeeding. Do not breastfeed while taking this medicine. If you become pregnant while taking torsemide, call your doctor.

  • you should know that torsemide may cause dizziness, lightheadedness, and fainting when you get up too quickly from a lying position. This is more common when you first start taking torsemide. To avoid this problem, get out of bed slowly, resting your feet on the floor for a few minutes before standing up. Alcohol can add to these side effects.

If your doctor prescribes a low-salt or low-sodium diet, or to eat or drink increased amounts of potassium-rich foods (e.g., bananas, prunes, raisins, and orange juice) in your diet, follow these instructions carefully.

Take the missed dose as soon as you remember it. However, if it is almost time for your next dose, skip the missed dose and continue your regular dosing schedule. Do not take a double dose to make up for a missed one.

  • Tell your doctor if any of these symptoms are severe or do not go away:

    • frequent urination

    • cough

    • constipation

    • diarrhea

    • hearing loss

    • ringing in ears

    • sore throat

    • headache

    • upset stomach

  • Some side effects can be serious. If you have any of these symptoms, call your doctor immediately or get emergency medical treatment:

    • dry mouth; thirst; nausea; vomiting; weakness, tiredness; drowsiness; restlessness; confusion; muscle weakness, pain, or cramps; fast heartbeat and other signs of dehydration and electrolyte imbalance

    • rapid, excessive weight loss

    • vomiting blood

    • chest pain

    • difficulty breathing or swallowing

    • blisters or peeling skin

    • hives

    • rash

    • itching

    • ongoing pain that begins in the stomach area, but may spread to the back

  • If you experience a serious side effect, you or your doctor may send a report to the Food and Drug Administration's (FDA) MedWatch Adverse Event Reporting program online (http://www.fda.gov/Safety/MedWatch) or by phone (1-800-332-1088).

Keep this medicine in the container it came in, tightly closed, and out of reach of children. Store it at room temperature and away from excess heat and moisture (not in the bathroom).

Unneeded medications should be disposed of in special ways to ensure that pets, children, and other people cannot consume them. However, you should not flush this medication down the toilet. Instead, the best way to dispose of your medication is through a medicine take-back program. Talk to your pharmacist or contact your local garbage/recycling department to learn about take-back programs in your community. See the FDA's Safe Disposal of Medicines website (http://goo.gl/c4Rm4p) for more information if you do not have access to a take-back program.

It is important to keep all medication out of sight and reach of children as many containers (such as weekly pill minders and those for eye drops, creams, patches, and inhalers) are not child-resistant and young children can open them easily. To protect young children from poisoning, always lock safety caps and immediately place the medication in a safe location – one that is up and away and out of their sight and reach. http://www.upandaway.org

In case of overdose, call the poison control helpline at 1-800-222-1222. Information is also available online at https://www.poisonhelp.org/help. If the victim has collapsed, had a seizure, has trouble breathing, or can't be awakened, immediately call emergency services at 911.

Keep all appointments with your doctor and the laboratory. Your blood pressure should be checked regularly, and blood tests should be done occasionally.

Before having any laboratory test, tell your doctor and the laboratory personnel that you are taking torsemide.

Do not let anyone else take your medicine. Ask your pharmacist any questions you have about refilling your prescription.

It is important for you to keep a written list of all of the prescription and nonprescription (over-the-counter) medicines you are taking, as well as any products such as vitamins, minerals, or other dietary supplements. You should bring this list with you each time you visit a doctor or if you are admitted to a hospital. It is also important information to carry with you in case of emergencies.

Drug Interaction
Repaglinide Repaglinide The therapeutic efficacy of Repaglinide can be increased when used in combination with Torasemide.
Montelukast Montelukast The metabolism of Torasemide can be decreased when combined with Montelukast.
Insulin Glargine (rDNA origin) Injection Insulin Glargine (rDNA origin) Injection The therapeutic efficacy of Insulin glargine can be decreased when used in combination with Torasemide.
Leflunomide Leflunomide The metabolism of Leflunomide can be decreased when combined with Torasemide.
Delavirdine Delavirdine The metabolism of Torasemide can be decreased when combined with Delavirdine.
Nevirapine Nevirapine The metabolism of Nevirapine can be decreased when combined with Torasemide.
Atorvastatin Atorvastatin The metabolism of Atorvastatin can be decreased when combined with Torasemide.
Alendronate Alendronate The risk or severity of hypocalcemia can be increased when Torasemide is combined with Alendronic acid.
Bisacodyl Bisacodyl The risk or severity of adverse effects can be increased when Torasemide is combined with Bisacodyl.
Candesartan Candesartan The metabolism of Torasemide can be decreased when combined with Candesartan.
Cilostazol Cilostazol Torasemide may increase the excretion rate of Cilostazol which could result in a lower serum level and potentially a reduction in efficacy.
Clopidogrel Clopidogrel The metabolism of Torasemide can be decreased when combined with Clopidogrel.
Diphenoxylate Diphenoxylate The therapeutic efficacy of Torasemide can be decreased when used in combination with Diphenoxylate.
Erythromycin and Sulfisoxazole Erythromycin and Sulfisoxazole The excretion of Torasemide can be decreased when combined with Erythromycin.
Estrogen and Progestin (Oral Contraceptives) Estrogen and Progestin (Oral Contraceptives) Torasemide may increase the excretion rate of Conjugated estrogens which could result in a lower serum level and potentially a reduction in efficacy.
Fenofibrate Fenofibrate The metabolism of Torasemide can be decreased when combined with Fenofibrate.
Guanfacine Guanfacine Torasemide may increase the excretion rate of Guanfacine which could result in a lower serum level and potentially a reduction in efficacy.
Magnesium Hydroxide Magnesium Hydroxide The risk or severity of adverse effects can be increased when Torasemide is combined with Magnesium hydroxide.
Magnesium Oxide Magnesium Oxide The risk or severity of adverse effects can be increased when Torasemide is combined with Magnesium oxide.
Methylergonovine Methylergonovine Methylergometrine may decrease the antihypertensive activities of Torasemide.
Miglitol Miglitol The therapeutic efficacy of Miglitol can be increased when used in combination with Torasemide.
Mycophenolate Mycophenolate Torasemide may increase the excretion rate of Mycophenolic acid which could result in a lower serum level and potentially a reduction in efficacy.
Naratriptan Naratriptan Naratriptan may decrease the antihypertensive activities of Torasemide.
Olsalazine Olsalazine The therapeutic efficacy of Torasemide can be decreased when used in combination with Olsalazine.
Paregoric Paregoric The metabolism of Morphine can be decreased when combined with Torasemide.
Penbutolol Penbutolol Torasemide may increase the hypotensive activities of Acebutolol.
Pentazocine Pentazocine The therapeutic efficacy of Torasemide can be decreased when used in combination with Pentazocine.
Polyethylene glycol-electrolyte solution (PEG-ES) Polyethylene glycol-electrolyte solution (PEG-ES) The risk or severity of adverse effects can be increased when Torasemide is combined with Polyethylene glycol.
Potassium Potassium Torasemide may increase the excretion rate of Potassium cation which could result in a lower serum level and potentially a reduction in efficacy.
Prednisone Prednisone Prednisone may increase the excretion rate of Torasemide which could result in a lower serum level and potentially a reduction in efficacy.
Psyllium Psyllium The risk or severity of adverse effects can be increased when Torasemide is combined with Plantago seed.
Ranitidine Ranitidine Torasemide may increase the excretion rate of Ranitidine which could result in a lower serum level and potentially a reduction in efficacy.
Reserpine Reserpine Reserpine may increase the excretion rate of Torasemide which could result in a lower serum level and potentially a reduction in efficacy.
Rizatriptan Rizatriptan Torasemide may increase the excretion rate of Rizatriptan which could result in a lower serum level and potentially a reduction in efficacy.
Sumatriptan Sumatriptan Torasemide may increase the excretion rate of Sumatriptan which could result in a lower serum level and potentially a reduction in efficacy.
Tacrolimus Tacrolimus The excretion of Torasemide can be decreased when combined with Tacrolimus.
Tiludronate Tiludronate The risk or severity of hypocalcemia can be increased when Torasemide is combined with Etidronic acid.
Tizanidine Tizanidine The risk or severity of adverse effects can be increased when Tizanidine is combined with Torasemide.
Triamcinolone Triamcinolone The risk or severity of hypokalemia can be increased when Triamcinolone is combined with Torasemide.
Zolmitriptan Zolmitriptan Zolmitriptan may decrease the antihypertensive activities of Torasemide.
Ampicillin Injection Ampicillin Injection Torasemide may increase the excretion rate of Ampicillin which could result in a lower serum level and potentially a reduction in efficacy.
Doxycycline Injection Doxycycline Injection Torasemide may increase the excretion rate of Doxycycline which could result in a lower serum level and potentially a reduction in efficacy.
Fluconazole Injection Fluconazole Injection The metabolism of Torasemide can be decreased when combined with Fluconazole.
Foscarnet Injection Foscarnet Injection Torasemide may decrease the excretion rate of Foscarnet which could result in a higher serum level.
Hydromorphone Injection Hydromorphone Injection The metabolism of Hydromorphone can be decreased when combined with Torasemide.
Levofloxacin Injection Levofloxacin Injection Torasemide may increase the excretion rate of Levofloxacin which could result in a lower serum level and potentially a reduction in efficacy.
Meperidine Injection Meperidine Injection The therapeutic efficacy of Torasemide can be decreased when used in combination with Meperidine.
Methylprednisolone Injection Methylprednisolone Injection The risk or severity of hypokalemia can be increased when Methylprednisolone is combined with Torasemide.
Metoclopramide Injection Metoclopramide Injection Torasemide may increase the excretion rate of Metoclopramide which could result in a lower serum level and potentially a reduction in efficacy.
Metronidazole Injection Metronidazole Injection The metabolism of Torasemide can be decreased when combined with Metronidazole.
Morphine Injection Morphine Injection The metabolism of Morphine can be decreased when combined with Torasemide.
Pamidronate Injection Pamidronate Injection The risk or severity of hypocalcemia can be increased when Torasemide is combined with Pamidronic acid.
Vancomycin Injection Vancomycin Injection Torasemide may increase the excretion rate of Vancomycin which could result in a lower serum level and potentially a reduction in efficacy.
Zidovudine Injection Zidovudine Injection The metabolism of Zidovudine can be decreased when combined with Torasemide.
Altretamine Altretamine Amphetamine may increase the hypotensive activities of Torasemide.
Cyclosporine Cyclosporine The risk or severity of renal failure can be increased when Cyclosporine is combined with Torasemide.
Ondansetron Ondansetron The metabolism of Ondansetron can be decreased when combined with Torasemide.
Olanzapine Olanzapine The risk or severity of adverse effects can be increased when Olanzapine is combined with Torasemide.
Alosetron Alosetron The metabolism of Alosetron can be decreased when combined with Torasemide.
Dofetilide Dofetilide The risk or severity of QTc prolongation, torsade de pointes, hypokalemia, hypomagnesemia, and cardiac arrest can be increased when Torasemide is combined with Dofetilide.
Eprosartan Eprosartan Torasemide may increase the hypotensive activities of Eprosartan.
Hydroxychloroquine Hydroxychloroquine The metabolism of Hydroxychloroquine can be decreased when combined with Torasemide.
Meloxicam Meloxicam The therapeutic efficacy of Torasemide can be decreased when used in combination with Meloxicam.
Pantoprazole Pantoprazole Torasemide may increase the excretion rate of Pantoprazole which could result in a lower serum level and potentially a reduction in efficacy.
Risedronate Risedronate The risk or severity of hypocalcemia can be increased when Torasemide is combined with Risedronic acid.
Sevelamer Sevelamer Sevelamer can cause a decrease in the absorption of Torasemide resulting in a reduced serum concentration and potentially a decrease in efficacy.
Telmisartan Telmisartan Torasemide may increase the hypotensive activities of Telmisartan.
Temozolomide Temozolomide Torasemide may increase the excretion rate of Temozolomide which could result in a lower serum level and potentially a reduction in efficacy.
Zaleplon Zaleplon Torasemide may increase the excretion rate of Zaleplon which could result in a lower serum level and potentially a reduction in efficacy.
Anakinra Anakinra The metabolism of Torasemide can be increased when combined with Anakinra.
Linezolid Linezolid Linezolid may increase the hypotensive activities of Torasemide.
Trimipramine Trimipramine The metabolism of Trimipramine can be decreased when combined with Torasemide.
Etanercept Injection Etanercept Injection The metabolism of Torasemide can be increased when combined with Etanercept.
Modafinil Modafinil The metabolism of Torasemide can be decreased when combined with Modafinil.
Perindopril Perindopril Torasemide may increase the excretion rate of Perindopril which could result in a lower serum level and potentially a reduction in efficacy.
Tenofovir Tenofovir Torasemide may increase the excretion rate of Tenofovir which could result in a lower serum level and potentially a reduction in efficacy.
Choline Magnesium Trisalicylate Choline Magnesium Trisalicylate The therapeutic efficacy of Torasemide can be decreased when used in combination with Choline magnesium trisalicylate.
Sirolimus Sirolimus The excretion of Torasemide can be decreased when combined with Sirolimus.
Dutasteride Dutasteride Dutasteride may decrease the antihypertensive activities of Torasemide.
Epinephrine Injection Epinephrine Injection The risk or severity of hypokalemia can be increased when Epinephrine is combined with Torasemide.
Eplerenone Eplerenone Torasemide may increase the hypotensive activities of Eplerenone.
Olmesartan Olmesartan Torasemide may increase the hypotensive activities of Olmesartan.
Zonisamide Zonisamide Torasemide may increase the excretion rate of Zonisamide which could result in a lower serum level and potentially a reduction in efficacy.
Adalimumab Injection Adalimumab Injection The metabolism of Torasemide can be increased when combined with Adalimumab.
Aripiprazole Aripiprazole The risk or severity of hypotension can be increased when Aripiprazole is combined with Torasemide.
Atomoxetine Atomoxetine Atomoxetine may increase the excretion rate of Torasemide which could result in a lower serum level and potentially a reduction in efficacy.
Dexmethylphenidate Dexmethylphenidate Dexmethylphenidate may decrease the antihypertensive activities of Torasemide.
Atazanavir Atazanavir The metabolism of Atazanavir can be decreased when combined with Torasemide.
Almotriptan Almotriptan The metabolism of Almotriptan can be decreased when combined with Torasemide.
Eletriptan Eletriptan The metabolism of Eletriptan can be decreased when combined with Torasemide.
Polyethylene Glycol 3350 Polyethylene Glycol 3350 The risk or severity of adverse effects can be increased when Torasemide is combined with Polyethylene glycol.
Rosuvastatin Rosuvastatin The metabolism of Rosuvastatin can be decreased when combined with Torasemide.
Vardenafil Vardenafil Vardenafil may increase the antihypertensive activities of Torasemide.
Alfuzosin Alfuzosin Alfuzosin may increase the hypotensive activities of Torasemide.
Aprepitant Aprepitant The metabolism of Torasemide can be decreased when combined with Aprepitant.
Emtricitabine Emtricitabine Torasemide may increase the excretion rate of Emtricitabine which could result in a lower serum level and potentially a reduction in efficacy.
Memantine Memantine Torasemide may increase the excretion rate of Memantine which could result in a lower serum level and potentially a reduction in efficacy.
Tegaserod Tegaserod The risk or severity of adverse effects can be increased when Torasemide is combined with Tegaserod.
Tadalafil Tadalafil Tadalafil may increase the excretion rate of Torasemide which could result in a lower serum level and potentially a reduction in efficacy.
Frovatriptan Frovatriptan Frovatriptan may decrease the antihypertensive activities of Torasemide.
Progesterone Progesterone The metabolism of Progesterone can be decreased when combined with Torasemide.
Apomorphine Injection Apomorphine Injection The metabolism of Torasemide can be decreased when combined with Apomorphine.
Infliximab Injection Infliximab Injection The metabolism of Torasemide can be increased when combined with Infliximab.
Oxandrolone Oxandrolone The metabolism of Torasemide can be decreased when combined with Oxandrolone.
Protriptyline Protriptyline Protriptyline may decrease the antihypertensive activities of Torasemide.
Rifaximin Rifaximin The metabolism of Torasemide can be increased when combined with Rifaximin.
Duloxetine Duloxetine The risk or severity of orthostatic hypotension and syncope can be increased when Torasemide is combined with Duloxetine.
Tinidazole Tinidazole Torasemide may increase the excretion rate of Tinidazole which could result in a lower serum level and potentially a reduction in efficacy.
Bosentan Bosentan The metabolism of Torasemide can be increased when combined with Bosentan.
Cefditoren Cefditoren Torasemide may increase the excretion rate of Cefdinir which could result in a lower serum level and potentially a reduction in efficacy.
Cyanocobalamin Injection Cyanocobalamin Injection Torasemide may increase the excretion rate of Hydroxocobalamin which could result in a lower serum level and potentially a reduction in efficacy.
Erlotinib Erlotinib The metabolism of Torasemide can be decreased when combined with Erlotinib.
Eszopiclone Eszopiclone The metabolism of Eszopiclone can be decreased when combined with Torasemide.
Ganciclovir Ganciclovir Torasemide may increase the excretion rate of Ganciclovir which could result in a lower serum level and potentially a reduction in efficacy.
Insulin Aspart (rDNA Origin) Injection Insulin Aspart (rDNA Origin) Injection The therapeutic efficacy of Insulin aspart can be increased when used in combination with Torasemide.
Ribavirin Ribavirin Torasemide may increase the excretion rate of Ribavirin which could result in a lower serum level and potentially a reduction in efficacy.
Solifenacin Solifenacin Solifenacin may decrease the antihypertensive activities of Torasemide.
Valganciclovir Valganciclovir Torasemide may increase the excretion rate of Valganciclovir which could result in a lower serum level and potentially a reduction in efficacy.
Voriconazole Voriconazole The metabolism of Voriconazole can be decreased when combined with Torasemide.
Zoledronic Acid Injection Zoledronic Acid Injection The risk or severity of hypocalcemia can be increased when Torasemide is combined with Zoledronic acid.
Dextroamphetamine Dextroamphetamine Amphetamine may increase the hypotensive activities of Torasemide.
Peginterferon Alfa-2b (PEG-Intron) Peginterferon Alfa-2b (PEG-Intron) The metabolism of Torasemide can be increased when combined with Peginterferon alfa-2b.
Pramlintide Injection Pramlintide Injection The therapeutic efficacy of Pramlintide can be increased when used in combination with Torasemide.
Exenatide Injection Exenatide Injection The therapeutic efficacy of Exenatide can be increased when used in combination with Torasemide.
Ibandronate Ibandronate The risk or severity of hypocalcemia can be increased when Torasemide is combined with Ibandronate.
Isocarboxazid Isocarboxazid Isocarboxazid may increase the hypotensive activities of Torasemide.
Ramelteon Ramelteon The metabolism of Ramelteon can be decreased when combined with Torasemide.
Fentanyl Fentanyl The therapeutic efficacy of Torasemide can be decreased when used in combination with Fentanyl.
Pregabalin Pregabalin Torasemide may increase the excretion rate of Pregabalin which could result in a lower serum level and potentially a reduction in efficacy.
Deferasirox Deferasirox The metabolism of Torasemide can be decreased when combined with Deferasirox.
Phenylephrine Phenylephrine Phenylephrine may decrease the antihypertensive activities of Torasemide.
Tipranavir Tipranavir The excretion of Torasemide can be decreased when combined with Tipranavir.
Felbamate Felbamate The metabolism of Torasemide can be decreased when combined with Felbamate.
Insulin Detemir (rDNA Origin) Injection Insulin Detemir (rDNA Origin) Injection The therapeutic efficacy of Insulin detemir can be decreased when used in combination with Torasemide.
Ranolazine Ranolazine Torasemide may increase the excretion rate of Ranolazine which could result in a lower serum level and potentially a reduction in efficacy.
Abatacept Injection Abatacept Injection The metabolism of Torasemide can be increased when combined with Abatacept.
Rasagiline Rasagiline Rasagiline may increase the hypotensive activities of Torasemide.
Imatinib Imatinib The metabolism of Torasemide can be decreased when combined with Imatinib.
Sitagliptin Sitagliptin The therapeutic efficacy of Sitagliptin can be increased when used in combination with Torasemide.
Varenicline Varenicline Torasemide may increase the excretion rate of Varenicline which could result in a lower serum level and potentially a reduction in efficacy.
Gefitinib Gefitinib The metabolism of Torasemide can be decreased when combined with Gefitinib.
Albuterol Albuterol The risk or severity of hypokalemia can be increased when Torasemide is combined with Salbutamol.
Paliperidone Paliperidone Torasemide may increase the excretion rate of Paliperidone which could result in a lower serum level and potentially a reduction in efficacy.
Bortezomib Bortezomib The metabolism of Torasemide can be decreased when combined with Bortezomib.
Clofarabine Injection Clofarabine Injection Clofarabine may increase the excretion rate of Torasemide which could result in a lower serum level and potentially a reduction in efficacy.
Insulin Glulisine (rDNA origin) Injection Insulin Glulisine (rDNA origin) Injection The therapeutic efficacy of Insulin glulisine can be increased when used in combination with Torasemide.
Lubiprostone Lubiprostone The risk or severity of adverse effects can be increased when Torasemide is combined with Lubiprostone.
Rituximab Injection Rituximab Injection Torasemide may increase the hypotensive activities of Rituximab.
Aliskiren Aliskiren Torasemide may increase the hypotensive activities of Aliskiren.
Bismuth Subsalicylate Bismuth Subsalicylate The risk or severity of adverse effects can be increased when Bismuth subsalicylate is combined with Torasemide.
Darunavir Darunavir The excretion of Torasemide can be decreased when combined with Darunavir.
Pemetrexed Injection Pemetrexed Injection Torasemide may increase the excretion rate of Pemetrexed which could result in a lower serum level and potentially a reduction in efficacy.
Lisdexamfetamine Lisdexamfetamine Lisdexamfetamine may decrease the antihypertensive activities of Torasemide.
Nabilone Nabilone The metabolism of Torasemide can be decreased when combined with Nabilone.
Sorafenib Sorafenib The metabolism of Torasemide can be decreased when combined with Sorafenib.
Sunitinib Sunitinib The therapeutic efficacy of Sunitinib can be increased when used in combination with Torasemide.
Dronabinol Dronabinol The metabolism of Dronabinol can be decreased when combined with Torasemide.
Lapatinib Lapatinib The metabolism of Torasemide can be decreased when combined with Lapatinib.
Levocetirizine Levocetirizine Torasemide may increase the excretion rate of Levocetirizine which could result in a lower serum level and potentially a reduction in efficacy.
Pegaptanib Injection Pegaptanib Injection Torasemide may increase the excretion rate of Pegaptanib which could result in a lower serum level and potentially a reduction in efficacy.
Armodafinil Armodafinil The metabolism of Torasemide can be decreased when combined with Armodafinil.
Azacitidine Injection Azacitidine Injection Torasemide may increase the excretion rate of Azacitidine which could result in a lower serum level and potentially a reduction in efficacy.
Ivermectin Ivermectin The excretion of Torasemide can be decreased when combined with Ivermectin.
Paclitaxel (with polyoxyethylated castor oil) Injection Paclitaxel (with polyoxyethylated castor oil) Injection The risk or severity of adverse effects can be increased when Torasemide is combined with Castor oil.
Lenalidomide Lenalidomide Torasemide may increase the excretion rate of Lenalidomide which could result in a lower serum level and potentially a reduction in efficacy.
Nilotinib Nilotinib The metabolism of Torasemide can be decreased when combined with Nilotinib.
Bexarotene Bexarotene The metabolism of Torasemide can be decreased when combined with Bexarotene.
Budesonide Budesonide Budesonide may increase the excretion rate of Torasemide which could result in a lower serum level and potentially a reduction in efficacy.
Desmopressin Desmopressin Torasemide may increase the excretion rate of Desmopressin which could result in a lower serum level and potentially a reduction in efficacy.
Doripenem Injection Doripenem Injection Torasemide may increase the excretion rate of Doripenem which could result in a lower serum level and potentially a reduction in efficacy.
Etravirine Etravirine The metabolism of Etravirine can be decreased when combined with Torasemide.
Arsenic Trioxide Injection Arsenic Trioxide Injection Arsenic trioxide may increase the excretion rate of Torasemide which could result in a lower serum level and potentially a reduction in efficacy.
Desvenlafaxine Desvenlafaxine Torasemide may increase the excretion rate of Desvenlafaxine which could result in a lower serum level and potentially a reduction in efficacy.
Cevimeline Cevimeline Torasemide may increase the excretion rate of Cevimeline which could result in a lower serum level and potentially a reduction in efficacy.
Nebivolol Nebivolol Torasemide may increase the hypotensive activities of Nebivolol.
Tretinoin Tretinoin The metabolism of Tretinoin can be decreased when combined with Torasemide.
Flecainide Flecainide The metabolism of Torasemide can be decreased when combined with Flecainide.
Certolizumab Injection Certolizumab Injection The metabolism of Torasemide can be increased when combined with Certolizumab pegol.
Irinotecan Injection Irinotecan Injection The excretion of Torasemide can be decreased when combined with Irinotecan.
Daptomycin Injection Daptomycin Injection Torasemide may increase the excretion rate of Daptomycin which could result in a lower serum level and potentially a reduction in efficacy.
Methylnaltrexone Injection Methylnaltrexone Injection Torasemide may increase the excretion rate of Methylnaltrexone which could result in a lower serum level and potentially a reduction in efficacy.
Midazolam Midazolam Torasemide may increase the excretion rate of Midazolam which could result in a lower serum level and potentially a reduction in efficacy.
Naltrexone Injection Naltrexone Injection The therapeutic efficacy of Torasemide can be decreased when used in combination with Naltrexone.
Dexrazoxane Injection Dexrazoxane Injection Torasemide may increase the excretion rate of Dexrazoxane which could result in a lower serum level and potentially a reduction in efficacy.
Eltrombopag Eltrombopag The metabolism of Torasemide can be decreased when combined with Eltrombopag.
Milnacipran Milnacipran Torasemide may increase the excretion rate of Milnacipran which could result in a lower serum level and potentially a reduction in efficacy.
Plerixafor Injection Plerixafor Injection Torasemide may increase the excretion rate of Plerixafor which could result in a lower serum level and potentially a reduction in efficacy.
Sodium Phosphate Sodium Phosphate Torasemide may increase the nephrotoxic activities of Sodium phosphate, monobasic.
Fesoterodine Fesoterodine Torasemide may increase the excretion rate of Fesoterodine which could result in a lower serum level and potentially a reduction in efficacy.
Betaxolol Betaxolol Betaxolol may increase the hypotensive activities of Torasemide.
Iloperidone Iloperidone Iloperidone may decrease the antihypertensive activities of Torasemide.
Prasugrel Prasugrel The metabolism of Prasugrel can be decreased when combined with Torasemide.
Lacosamide Lacosamide The metabolism of Lacosamide can be decreased when combined with Torasemide.
Everolimus Everolimus The excretion of Torasemide can be decreased when combined with Everolimus.
Dronedarone Dronedarone Dronedarone may decrease the antihypertensive activities of Torasemide.
Pralatrexate Injection Pralatrexate Injection Torasemide may increase the excretion rate of Pralatrexate which could result in a lower serum level and potentially a reduction in efficacy.
Palonosetron Injection Palonosetron Injection Torasemide may increase the excretion rate of Palonosetron which could result in a lower serum level and potentially a reduction in efficacy.
Saxagliptin Saxagliptin The therapeutic efficacy of Saxagliptin can be increased when used in combination with Torasemide.
Telavancin Injection Telavancin Injection Torasemide may increase the excretion rate of Telavancin which could result in a lower serum level and potentially a reduction in efficacy.
Tapentadol Tapentadol The metabolism of Tapentadol can be decreased when combined with Torasemide.
Topotecan Topotecan Torasemide may increase the excretion rate of Topotecan which could result in a lower serum level and potentially a reduction in efficacy.
Golimumab Injection Golimumab Injection The metabolism of Torasemide can be increased when combined with Golimumab.
Pazopanib Pazopanib The metabolism of Pazopanib can be decreased when combined with Torasemide.
Asenapine Asenapine Asenapine may decrease the antihypertensive activities of Torasemide.
Pitavastatin Pitavastatin The metabolism of Pitavastatin can be decreased when combined with Torasemide.
Oxymorphone Oxymorphone The therapeutic efficacy of Torasemide can be decreased when used in combination with Oxymorphone.
Liraglutide Injection Liraglutide Injection The therapeutic efficacy of Liraglutide can be increased when used in combination with Torasemide.
Tocilizumab Injection Tocilizumab Injection The metabolism of Torasemide can be increased when combined with Tocilizumab.
Dalfampridine Dalfampridine Torasemide may increase the excretion rate of Dalfampridine which could result in a lower serum level and potentially a reduction in efficacy.
Cabazitaxel Injection Cabazitaxel Injection The metabolism of Cabazitaxel can be decreased when combined with Torasemide.
Lurasidone Lurasidone Lurasidone may decrease the antihypertensive activities of Torasemide.
Acetaminophen Injection Acetaminophen Injection Torasemide may increase the excretion rate of Acetaminophen which could result in a lower serum level and potentially a reduction in efficacy.
Vilazodone Vilazodone Vilazodone may decrease the antihypertensive activities of Torasemide.
Ipilimumab Injection Ipilimumab Injection Torasemide may increase the excretion rate of Ipilimumab which could result in a lower serum level and potentially a reduction in efficacy.
Denileukin Diftitox Injection Denileukin Diftitox Injection Aldesleukin may increase the excretion rate of Torasemide which could result in a lower serum level and potentially a reduction in efficacy.
Terbutaline Injection Terbutaline Injection The risk or severity of hypokalemia can be increased when Torasemide is combined with Terbutaline.
Azilsartan Azilsartan The risk or severity of adverse effects can be increased when Azilsartan medoxomil is combined with Torasemide.
Roflumilast Roflumilast Torasemide may increase the excretion rate of Roflumilast which could result in a lower serum level and potentially a reduction in efficacy.
Linagliptin Linagliptin The therapeutic efficacy of Linagliptin can be increased when used in combination with Torasemide.
Rilpivirine Rilpivirine The excretion of Torasemide can be decreased when combined with Rilpivirine.
Telaprevir Telaprevir The excretion of Torasemide can be decreased when combined with Glecaprevir.
Cyclophosphamide Injection Cyclophosphamide Injection The metabolism of Torasemide can be decreased when combined with Cyclophosphamide.
Abiraterone Abiraterone The metabolism of Torasemide can be decreased when combined with Abiraterone.
Rivaroxaban Rivaroxaban Torasemide may increase the excretion rate of Rivaroxaban which could result in a lower serum level and potentially a reduction in efficacy.
Ticagrelor Ticagrelor The metabolism of Torasemide can be decreased when combined with Ticagrelor.
Ruxolitinib Ruxolitinib Torasemide may increase the excretion rate of Ruxolitinib which could result in a lower serum level and potentially a reduction in efficacy.
Clobazam Clobazam Torasemide may increase the excretion rate of Clobazam which could result in a lower serum level and potentially a reduction in efficacy.
Vemurafenib Vemurafenib The metabolism of Torasemide can be decreased when combined with Vemurafenib.
Vismodegib Vismodegib The metabolism of Torasemide can be decreased when combined with Vismodegib.
Deferiprone Deferiprone Torasemide may increase the excretion rate of Deferiprone which could result in a lower serum level and potentially a reduction in efficacy.
Axitinib Axitinib The excretion of Torasemide can be decreased when combined with Axitinib.
Cabergoline Cabergoline Cabergoline may decrease the antihypertensive activities of Torasemide.
Naloxone Injection Naloxone Injection Torasemide may increase the excretion rate of Naloxone which could result in a lower serum level and potentially a reduction in efficacy.
Ambrisentan Ambrisentan Torasemide may increase the hypotensive activities of Ambrisentan.
Fondaparinux Injection Fondaparinux Injection Torasemide may increase the excretion rate of Fondaparinux which could result in a lower serum level and potentially a reduction in efficacy.
Iloprost Iloprost Iloprost may increase the hypotensive activities of Torasemide.
Enzalutamide Enzalutamide The metabolism of Torasemide can be decreased when combined with Enzalutamide.
Mirabegron Mirabegron Torasemide may increase the excretion rate of Mirabegron which could result in a lower serum level and potentially a reduction in efficacy.
Regorafenib Regorafenib The metabolism of Torasemide can be decreased when combined with Regorafenib.
Bosutinib Bosutinib The metabolism of Torasemide can be decreased when combined with Bosutinib.
Corticotropin, Repository Injection Corticotropin, Repository Injection The risk or severity of hypokalemia can be increased when Corticotropin is combined with Torasemide.
Linaclotide Linaclotide The risk or severity of adverse effects can be increased when Torasemide is combined with Linaclotide.
Teriflunomide Teriflunomide The metabolism of Torasemide can be decreased when combined with Teriflunomide.
Lorcaserin Lorcaserin The therapeutic efficacy of Mecasermin can be increased when used in combination with Torasemide.
Cabozantinib (thyroid cancer) Cabozantinib (thyroid cancer) The metabolism of Cabozantinib can be decreased when combined with Torasemide.
Teduglutide Injection Teduglutide Injection Torasemide may increase the excretion rate of Teduglutide which could result in a lower serum level and potentially a reduction in efficacy.
Alogliptin Alogliptin The therapeutic efficacy of Alogliptin can be increased when used in combination with Torasemide.
Ponatinib Ponatinib The metabolism of Torasemide can be decreased when combined with Ponatinib.
Pomalidomide Pomalidomide Torasemide may increase the excretion rate of Pomalidomide which could result in a lower serum level and potentially a reduction in efficacy.
Apixaban Apixaban The metabolism of Apixaban can be decreased when combined with Torasemide.
Canagliflozin Canagliflozin The risk or severity of hypotension can be increased when Canagliflozin is combined with Torasemide.
Methazolamide Methazolamide The risk or severity of adverse effects can be increased when Methazolamide is combined with Torasemide.
Dabrafenib Dabrafenib The metabolism of Torasemide can be decreased when combined with Dabrafenib.
Ospemifene Ospemifene The metabolism of Ospemifene can be decreased when combined with Torasemide.
Trametinib Trametinib The metabolism of Torasemide can be decreased when combined with Trametinib.
Levomilnacipran Levomilnacipran The metabolism of Levomilnacipran can be decreased when combined with Torasemide.
Ertapenem Injection Ertapenem Injection Torasemide may increase the excretion rate of Ertapenem which could result in a lower serum level and potentially a reduction in efficacy.
Vortioxetine Vortioxetine The metabolism of Vortioxetine can be decreased when combined with Torasemide.
Avanafil Avanafil Avanafil may increase the antihypertensive activities of Torasemide.
Ketorolac Injection Ketorolac Injection The therapeutic efficacy of Torasemide can be decreased when used in combination with Ketorolac.
Obinutuzumab Injection Obinutuzumab Injection Torasemide may increase the hypotensive activities of Obinutuzumab.
Simeprevir Simeprevir The excretion of Torasemide can be decreased when combined with Simeprevir.
Sofosbuvir Sofosbuvir Torasemide may increase the excretion rate of Sofosbuvir which could result in a lower serum level and potentially a reduction in efficacy.
Dapagliflozin Dapagliflozin The therapeutic efficacy of Dapagliflozin can be increased when used in combination with Torasemide.
Apremilast Apremilast The metabolism of Torasemide can be increased when combined with Apremilast.
Droxidopa Droxidopa The risk or severity of hypokalemia can be increased when Droxidopa is combined with Torasemide.
Ceritinib Ceritinib The metabolism of Torasemide can be decreased when combined with Ceritinib.
Siltuximab Injection Siltuximab Injection The metabolism of Torasemide can be increased when combined with Siltuximab.
Albiglutide Injection Albiglutide Injection The therapeutic efficacy of Albiglutide can be increased when used in combination with Torasemide.
Idelalisib Idelalisib The excretion of Torasemide can be decreased when combined with Idelalisib.
Testosterone Injection Testosterone Injection The metabolism of Testosterone can be decreased when combined with Torasemide.
Oritavancin Injection Oritavancin Injection The metabolism of Torasemide can be decreased when combined with Oritavancin.
Empagliflozin Empagliflozin Torasemide may increase the diuretic activities of Empagliflozin.
Hydrocodone Hydrocodone The therapeutic efficacy of Torasemide can be decreased when used in combination with Hydrocodone.
Dulaglutide Injection Dulaglutide Injection The therapeutic efficacy of Dulaglutide can be increased when used in combination with Torasemide.
Edoxaban Edoxaban Torasemide may increase the excretion rate of Edoxaban which could result in a lower serum level and potentially a reduction in efficacy.
Caspofungin Injection Caspofungin Injection The excretion of Torasemide can be decreased when combined with Caspofungin.
Methamphetamine Methamphetamine Torasemide may increase the excretion rate of Metamfetamine which could result in a lower serum level and potentially a reduction in efficacy.
Tasimelteon Tasimelteon Torasemide may increase the excretion rate of Tasimelteon which could result in a lower serum level and potentially a reduction in efficacy.
Riociguat Riociguat The metabolism of Riociguat can be decreased when combined with Torasemide.
Secukinumab Injection Secukinumab Injection The metabolism of Torasemide can be increased when combined with Secukinumab.
Risperidone Injection Risperidone Injection The risk or severity of hypotension can be increased when Torasemide is combined with Risperidone.
Insulin Human Inhalation Insulin Human Inhalation The therapeutic efficacy of Insulin human can be increased when used in combination with Torasemide.
Lenvatinib Lenvatinib The metabolism of Torasemide can be decreased when combined with Lenvatinib.
Dinutuximab Injection Dinutuximab Injection The risk or severity of adverse effects can be increased when Dinutuximab is combined with Torasemide.
Haloperidol Injection Haloperidol Injection The metabolism of Haloperidol can be decreased when combined with Torasemide.
Ivabradine Ivabradine The risk or severity of Cardiac Arrhythmia can be increased when Torasemide is combined with Ivabradine.
Amiloride Amiloride The risk or severity of adverse effects can be increased when Amiloride is combined with Torasemide.
Macitentan Macitentan Torasemide may increase the excretion rate of Macitentan which could result in a lower serum level and potentially a reduction in efficacy.
Flibanserin Flibanserin Flibanserin may decrease the antihypertensive activities of Torasemide.
Prednisolone Prednisolone The risk or severity of hypokalemia can be increased when Prednisolone is combined with Torasemide.
Daclatasvir Daclatasvir The excretion of Torasemide can be decreased when combined with Daclatasvir.
Brexpiprazole Brexpiprazole Brexpiprazole may decrease the antihypertensive activities of Torasemide.
Ziprasidone Injection Ziprasidone Injection Ziprasidone may increase the antihypertensive activities of Torasemide.
Cariprazine Cariprazine Cariprazine may decrease the antihypertensive activities of Torasemide.
Penicillin G Procaine Injection Penicillin G Procaine Injection Torasemide may increase the excretion rate of Procaine benzylpenicillin which could result in a lower serum level and potentially a reduction in efficacy.
Eluxadoline Eluxadoline The therapeutic efficacy of Torasemide can be decreased when used in combination with Eluxadoline.
Insulin Degludec (rDNA Origin) Injection Insulin Degludec (rDNA Origin) Injection The therapeutic efficacy of Insulin degludec can be increased when used in combination with Torasemide.
Trabectedin Injection Trabectedin Injection The metabolism of Trabectedin can be decreased when combined with Torasemide.
Ixazomib Ixazomib Torasemide may increase the excretion rate of Ixazomib which could result in a lower serum level and potentially a reduction in efficacy.
Rifapentine Rifapentine The metabolism of Torasemide can be increased when combined with Rifapentine.
Lesinurad Lesinurad The metabolism of Lesinurad can be decreased when combined with Torasemide.
Amphotericin B Liposomal Injection Amphotericin B Liposomal Injection The risk or severity of adverse effects can be increased when Amphotericin B is combined with Torasemide.
Dexamethasone Injection Dexamethasone Injection The metabolism of Torasemide can be increased when combined with Dexamethasone.
Brivaracetam Injection Brivaracetam Injection The metabolism of Brivaracetam can be decreased when combined with Torasemide.
Venetoclax Venetoclax The excretion of Torasemide can be decreased when combined with Venetoclax.
Cobicistat Cobicistat The excretion of Torasemide can be decreased when combined with Cobicistat.
Midodrine Midodrine Midodrine may decrease the antihypertensive activities of Torasemide.
Selexipag Selexipag The metabolism of Selexipag can be decreased when combined with Torasemide.
Diphenhydramine Injection Diphenhydramine Injection The metabolism of Diphenhydramine can be decreased when combined with Torasemide.
Furosemide Injection Furosemide Injection The risk or severity of ototoxicity can be increased when Furosemide is combined with Torasemide.
Rucaparib Rucaparib The metabolism of Torasemide can be decreased when combined with Rucaparib.
Lixisenatide Injection Lixisenatide Injection The therapeutic efficacy of Lixisenatide can be increased when used in combination with Torasemide.
Brigatinib Brigatinib The metabolism of Brigatinib can be decreased when combined with Torasemide.
Doxepin (Insomnia) Doxepin (Insomnia) The metabolism of Doxepin can be decreased when combined with Torasemide.
Plecanatide Plecanatide The risk or severity of adverse effects can be increased when Torasemide is combined with Plecanatide.
Deutetrabenazine Deutetrabenazine Torasemide may increase the excretion rate of Deutetrabenazine which could result in a lower serum level and potentially a reduction in efficacy.
Valbenazine Valbenazine Torasemide may increase the excretion rate of Valbenazine which could result in a lower serum level and potentially a reduction in efficacy.
Deflazacort Deflazacort The risk or severity of hypokalemia can be increased when Deflazacort is combined with Torasemide.
Safinamide Safinamide Safinamide may increase the hypotensive activities of Torasemide.
Naldemedine Naldemedine Torasemide may increase the excretion rate of Naldemedine which could result in a lower serum level and potentially a reduction in efficacy.
Midostaurin Midostaurin The metabolism of Torasemide can be decreased when combined with Midostaurin.
Enasidenib Enasidenib The metabolism of Torasemide can be decreased when combined with Enasidenib.
Benznidazole Benznidazole Torasemide may increase the excretion rate of Benznidazole which could result in a lower serum level and potentially a reduction in efficacy.
Delafloxacin Delafloxacin Delafloxacin may increase the excretion rate of Torasemide which could result in a lower serum level and potentially a reduction in efficacy.
Letermovir Letermovir The metabolism of Torasemide can be decreased when combined with Letermovir.
Semaglutide Injection Semaglutide Injection The therapeutic efficacy of Semaglutide can be increased when used in combination with Torasemide.
Ertugliflozin Ertugliflozin The therapeutic efficacy of Ertugliflozin can be decreased when used in combination with Torasemide.
Buprenorphine Injection Buprenorphine Injection The metabolism of Buprenorphine can be decreased when combined with Torasemide.
Apalutamide Apalutamide The metabolism of Apalutamide can be decreased when combined with Torasemide.
Fostamatinib Fostamatinib Fostamatinib may increase the antihypertensive activities of Torasemide.
Avatrombopag Avatrombopag The metabolism of Torasemide can be increased when combined with Avatrombopag.
Baricitinib Baricitinib Torasemide may increase the excretion rate of Baricitinib which could result in a lower serum level and potentially a reduction in efficacy.
Lofexidine Lofexidine Torasemide may increase the excretion rate of Lofexidine which could result in a lower serum level and potentially a reduction in efficacy.
Plazomicin Injection Plazomicin Injection The serum concentration of Plazomicin can be increased when it is combined with Torasemide.
Elagolix Elagolix The metabolism of Elagolix can be decreased when combined with Torasemide.
Cannabidiol Cannabidiol The metabolism of Cannabidiol can be decreased when combined with Torasemide.
Dacomitinib Dacomitinib The metabolism of Dacomitinib can be decreased when combined with Torasemide.
Stiripentol Stiripentol The metabolism of Torasemide can be decreased when combined with Stiripentol.
Glasdegib Glasdegib The metabolism of Glasdegib can be decreased when combined with Torasemide.
Lorlatinib Lorlatinib The metabolism of Lorlatinib can be decreased when combined with Torasemide.
Paclitaxel (with albumin) Injection Paclitaxel (with albumin) Injection The metabolism of Paclitaxel can be decreased when combined with Torasemide.
Rifamycin Rifamycin The metabolism of Torasemide can be increased when combined with Rifamycin.
Prucalopride Prucalopride The risk or severity of adverse effects can be increased when Torasemide is combined with Prucalopride.
Magnesium Citrate Magnesium Citrate The risk or severity of adverse effects can be increased when Torasemide is combined with Magnesium citrate.
Emapalumab-lzsg Injection Emapalumab-lzsg Injection The metabolism of Torasemide can be increased when combined with Emapalumab.
Siponimod Siponimod The metabolism of Torasemide can be decreased when combined with Siponimod.
Acyclovir Ophthalmic Acyclovir Ophthalmic Torasemide may increase the excretion rate of Acyclovir which could result in a lower serum level and potentially a reduction in efficacy.
Erdafitinib Erdafitinib The metabolism of Erdafitinib can be decreased when combined with Torasemide.
Alpelisib Alpelisib The serum concentration of Torasemide can be decreased when it is combined with Alpelisib.
Solriamfetol Solriamfetol Solriamfetol may increase the excretion rate of Torasemide which could result in a lower serum level and potentially a reduction in efficacy.
Triclabendazole Triclabendazole The metabolism of Torasemide can be decreased when combined with Triclabendazole.
Pexidartinib Pexidartinib The excretion of Torasemide can be decreased when combined with Pexidartinib.
Istradefylline Istradefylline The metabolism of Istradefylline can be decreased when combined with Torasemide.
Pitolisant Pitolisant Torasemide may increase the excretion rate of Pitolisant which could result in a lower serum level and potentially a reduction in efficacy.
Fedratinib Fedratinib The excretion of Torasemide can be decreased when combined with Fedratinib.
Phenytoin Injection Phenytoin Injection The metabolism of Phenytoin can be decreased when combined with Torasemide.
Fosphenytoin Injection Fosphenytoin Injection The metabolism of Fosphenytoin can be decreased when combined with Torasemide.
Voxelotor Voxelotor The metabolism of Voxelotor can be decreased when combined with Torasemide.
Avapritinib Avapritinib The metabolism of Avapritinib can be decreased when combined with Torasemide.
Bempedoic Acid Bempedoic Acid The excretion of Torasemide can be decreased when combined with Bempedoic acid.
Cenobamate Cenobamate The metabolism of Torasemide can be increased when combined with Cenobamate.
Teprotumumab-trbw Injection Teprotumumab-trbw Injection The risk or severity of ototoxicity can be increased when Torasemide is combined with Teprotumumab.
Ozanimod Ozanimod The metabolism of Ozanimod can be decreased when combined with Torasemide.
Selumetinib Selumetinib The metabolism of Selumetinib can be decreased when combined with Torasemide.
Tucatinib Tucatinib The metabolism of Tucatinib can be decreased when combined with Torasemide.
Remdesivir Injection Remdesivir Injection The excretion of Torasemide can be decreased when combined with Remdesivir.
Selpercatinib Selpercatinib The serum concentration of Torasemide can be increased when it is combined with Selpercatinib.
Fostemsavir Fostemsavir The excretion of Torasemide can be decreased when combined with Fostemsavir.
Pralsetinib Pralsetinib The metabolism of Torasemide can be decreased when combined with Pralsetinib.
Opicapone Opicapone The metabolism of Torasemide can be decreased when combined with Opicapone.
Satralizumab-mwge Injection Satralizumab-mwge Injection The serum concentration of Torasemide can be decreased when it is combined with Satralizumab.
Naxitamab-gqgk Injection Naxitamab-gqgk Injection Naxitamab may decrease the antihypertensive activities of Torasemide.
Viloxazine Viloxazine Torasemide may increase the excretion rate of Viloxazine which could result in a lower serum level and potentially a reduction in efficacy.
Tobramycin Injection Tobramycin Injection The serum concentration of Tobramycin can be increased when it is combined with Torasemide.
Theophylline Theophylline The metabolism of Theophylline can be decreased when combined with Torasemide.
Fenoprofen Fenoprofen The therapeutic efficacy of Torasemide can be decreased when used in combination with Fenoprofen.
Indomethacin Indomethacin The therapeutic efficacy of Torasemide can be decreased when used in combination with Indomethacin.
Mefenamic Acid Mefenamic Acid The therapeutic efficacy of Torasemide can be decreased when used in combination with Mefenamic acid.
Naproxen Naproxen The therapeutic efficacy of Torasemide can be decreased when used in combination with Naproxen.
Tolmetin Tolmetin The therapeutic efficacy of Torasemide can be decreased when used in combination with Tolmetin.
Sulindac Sulindac The therapeutic efficacy of Torasemide can be decreased when used in combination with Sulindac.
Trazodone Trazodone Trazodone may decrease the antihypertensive activities of Torasemide.
Isotretinoin Isotretinoin Torasemide may increase the excretion rate of Isotretinoin which could result in a lower serum level and potentially a reduction in efficacy.
Sucralfate Sucralfate Torasemide may increase the excretion rate of Sucralfate which could result in a lower serum level and potentially a reduction in efficacy.
Floxuridine Floxuridine The metabolism of Torasemide can be decreased when combined with Floxuridine.
Phenobarbital Phenobarbital The metabolism of Torasemide can be decreased when combined with Phenobarbital.
Metaxalone Metaxalone Torasemide may increase the excretion rate of Metaxalone which could result in a lower serum level and potentially a reduction in efficacy.
Methotrexate Injection Methotrexate Injection The risk or severity of adverse effects can be increased when Methotrexate is combined with Torasemide.
Levorphanol Levorphanol The therapeutic efficacy of Torasemide can be decreased when used in combination with Levorphanol.
Primidone Primidone The metabolism of Primidone can be decreased when combined with Torasemide.
Diethylpropion Diethylpropion Diethylpropion may decrease the antihypertensive activities of Torasemide.
Chlorpromazine Chlorpromazine Chlorpromazine may increase the excretion rate of Torasemide which could result in a lower serum level and potentially a reduction in efficacy.
Diazepam Diazepam The metabolism of Diazepam can be decreased when combined with Torasemide.
Oxazepam Oxazepam Torasemide may increase the excretion rate of Oxazepam which could result in a lower serum level and potentially a reduction in efficacy.
Flurazepam Flurazepam Torasemide may increase the excretion rate of Flurazepam which could result in a lower serum level and potentially a reduction in efficacy.
Clorazepate Clorazepate Torasemide may increase the excretion rate of Clorazepic acid which could result in a lower serum level and potentially a reduction in efficacy.
Lorazepam Lorazepam Torasemide may increase the excretion rate of Lorazepam which could result in a lower serum level and potentially a reduction in efficacy.
Phenoxybenzamine Phenoxybenzamine Torasemide may decrease the antihypertensive activities of Phenoxybenzamine.
Carmustine Carmustine Torasemide may increase the excretion rate of Carmustine which could result in a lower serum level and potentially a reduction in efficacy.
Amantadine Amantadine Torasemide may increase the excretion rate of Amantadine which could result in a lower serum level and potentially a reduction in efficacy.
Codeine Codeine The therapeutic efficacy of Torasemide can be decreased when used in combination with Codeine.
Bromocriptine Bromocriptine The therapeutic efficacy of Bromocriptine can be increased when used in combination with Torasemide.
Metaproterenol Metaproterenol The risk or severity of hypokalemia can be increased when Orciprenaline is combined with Torasemide.
Tranylcypromine Tranylcypromine Tranylcypromine may increase the hypotensive activities of Torasemide.
Phenelzine Phenelzine Phenelzine may increase the hypotensive activities of Torasemide.
Procarbazine Procarbazine Procarbazine may increase the hypotensive activities of Torasemide.
Ergoloid Mesylates Ergoloid Mesylates Ergoloid mesylate may decrease the antihypertensive activities of Torasemide.
Tetracycline Tetracycline Torasemide may increase the excretion rate of Tetracycline which could result in a lower serum level and potentially a reduction in efficacy.
Thioridazine Thioridazine Thioridazine may decrease the antihypertensive activities of Torasemide.
Trifluoperazine Trifluoperazine Trifluoperazine may decrease the antihypertensive activities of Torasemide.
Bleomycin Bleomycin Torasemide may increase the excretion rate of Bleomycin which could result in a lower serum level and potentially a reduction in efficacy.
Dapsone Dapsone The metabolism of Dapsone can be decreased when combined with Torasemide.
Sulfadiazine Sulfadiazine The therapeutic efficacy of Sulfadiazine can be increased when used in combination with Torasemide.
Oxycodone Oxycodone The therapeutic efficacy of Torasemide can be decreased when used in combination with Oxycodone.
Methadone Methadone The metabolism of Methadone can be decreased when combined with Torasemide.
Oxybutynin Oxybutynin The metabolism of Torasemide can be decreased when combined with Oxybutynin.
Benztropine Benztropine Torasemide may increase the excretion rate of Benzatropine which could result in a lower serum level and potentially a reduction in efficacy.
Colestipol Colestipol Colestipol can cause a decrease in the absorption of Torasemide resulting in a reduced serum concentration and potentially a decrease in efficacy.
Maprotiline Maprotiline Torasemide may increase the excretion rate of Maprotiline which could result in a lower serum level and potentially a reduction in efficacy.
Ibuprofen Ibuprofen The therapeutic efficacy of Torasemide can be decreased when used in combination with Ibuprofen.
Azathioprine Azathioprine Torasemide may increase the excretion rate of Azathioprine which could result in a lower serum level and potentially a reduction in efficacy.
Phentermine Phentermine Phentermine may decrease the antihypertensive activities of Torasemide.
Methylphenidate Methylphenidate Methylphenidate may decrease the antihypertensive activities of Torasemide.
Amoxapine Amoxapine Amoxapine may decrease the antihypertensive activities of Torasemide.
Sulfasalazine Sulfasalazine The therapeutic efficacy of Torasemide can be decreased when used in combination with Sulfasalazine.
Hydrocortisone Hydrocortisone The metabolism of Torasemide can be increased when combined with Hydrocortisone.
Phenazopyridine Phenazopyridine Torasemide may increase the excretion rate of Phenazopyridine which could result in a lower serum level and potentially a reduction in efficacy.
Carbamazepine Carbamazepine Torasemide may increase the excretion rate of Carbamazepine which could result in a lower serum level and potentially a reduction in efficacy.
Methyldopa Methyldopa Torasemide may increase the excretion rate of Methyldopa which could result in a lower serum level and potentially a reduction in efficacy.
Clonidine Clonidine The risk or severity of hypotension can be increased when Clonidine is combined with Torasemide.
Prazosin Prazosin The risk or severity of hypotension can be increased when Prazosin is combined with Torasemide.
Hydralazine Hydralazine Torasemide may increase the excretion rate of Hydralazine which could result in a lower serum level and potentially a reduction in efficacy.
Cimetidine Cimetidine The metabolism of Torasemide can be decreased when combined with Cimetidine.
Gentamicin Injection Gentamicin Injection The serum concentration of Gentamicin can be increased when it is combined with Torasemide.
Clonazepam Clonazepam Torasemide may increase the excretion rate of Clonazepam which could result in a lower serum level and potentially a reduction in efficacy.
Loperamide Loperamide The metabolism of Loperamide can be decreased when combined with Torasemide.
Promethazine Promethazine The metabolism of Torasemide can be decreased when combined with Promethazine.
Meclofenamate Meclofenamate The therapeutic efficacy of Torasemide can be decreased when used in combination with Meclofenamic acid.
Nitrofurantoin Nitrofurantoin Torasemide may increase the excretion rate of Nitrofurantoin which could result in a lower serum level and potentially a reduction in efficacy.
Griseofulvin Griseofulvin The metabolism of Torasemide can be increased when combined with Griseofulvin.
Chloroquine Chloroquine The metabolism of Chloroquine can be decreased when combined with Torasemide.
Quinine Quinine The metabolism of Torasemide can be decreased when combined with Quinine.
Triamterene Triamterene The risk or severity of adverse effects can be increased when Triamterene is combined with Torasemide.
Lactulose Lactulose The risk or severity of adverse effects can be increased when Torasemide is combined with Lactulose.
Sulfinpyrazone Sulfinpyrazone The metabolism of Torasemide can be decreased when combined with Sulfinpyrazone.
Chlorothiazide Chlorothiazide The therapeutic efficacy of Chlorothiazide can be increased when used in combination with Torasemide.
Chlorthalidone Chlorthalidone Torasemide may increase the hypotensive activities of Chlorthalidone.
Metolazone Metolazone Torasemide may increase the excretion rate of Metolazone which could result in a lower serum level and potentially a reduction in efficacy.
Secobarbital Secobarbital The metabolism of Torasemide can be increased when combined with Secobarbital.
Desipramine Desipramine Torasemide may increase the excretion rate of Desipramine which could result in a lower serum level and potentially a reduction in efficacy.
Amitriptyline Amitriptyline The metabolism of Amitriptyline can be decreased when combined with Torasemide.
Imipramine Imipramine Imipramine may increase the excretion rate of Torasemide which could result in a lower serum level and potentially a reduction in efficacy.
Probenecid Probenecid The risk or severity of adverse effects can be increased when Probenecid is combined with Torasemide.
Quinidine Quinidine The metabolism of Torasemide can be decreased when combined with Quinidine.
Procainamide Procainamide Torasemide may increase the excretion rate of Procainamide which could result in a lower serum level and potentially a reduction in efficacy.
Isoniazid Isoniazid The metabolism of Torasemide can be decreased when combined with Isoniazid.
Pyrazinamide Pyrazinamide Torasemide may increase the excretion rate of Pyrazinamide which could result in a lower serum level and potentially a reduction in efficacy.
Rifampin Rifampin The metabolism of Torasemide can be increased when combined with Rifampicin.
Disopyramide Disopyramide The therapeutic efficacy of Disopyramide can be increased when used in combination with Torasemide.
Valproic Acid Valproic Acid The metabolism of Torasemide can be decreased when combined with Valproic acid.
Tamoxifen Tamoxifen The metabolism of Torasemide can be decreased when combined with Tamoxifen.
Butabarbital Butabarbital Torasemide may increase the excretion rate of Butabarbital which could result in a lower serum level and potentially a reduction in efficacy.
Levothyroxine Levothyroxine The metabolism of Torasemide can be decreased when combined with Levothyroxine.
Liothyronine Liothyronine Torasemide may increase the excretion rate of Liothyronine which could result in a lower serum level and potentially a reduction in efficacy.
Methimazole Methimazole The metabolism of Torasemide can be decreased when combined with Methimazole.
Chlorpropamide Chlorpropamide The therapeutic efficacy of Chlorpropamide can be increased when used in combination with Torasemide.
Tolbutamide Tolbutamide The therapeutic efficacy of Tolbutamide can be increased when used in combination with Torasemide.
Tolazamide Tolazamide The therapeutic efficacy of Tolazamide can be increased when used in combination with Torasemide.
Dextromethorphan Dextromethorphan The metabolism of Dextromethorphan can be decreased when combined with Torasemide.
Baclofen Baclofen The risk or severity of adverse effects can be increased when Baclofen is combined with Torasemide.
Ethambutol Ethambutol Torasemide may increase the excretion rate of Ethambutol which could result in a lower serum level and potentially a reduction in efficacy.
Methyclothiazide Methyclothiazide The therapeutic efficacy of Torasemide can be increased when used in combination with Methyclothiazide.
Hydrochlorothiazide Hydrochlorothiazide The therapeutic efficacy of Hydrochlorothiazide can be increased when used in combination with Torasemide.
Chlorzoxazone Chlorzoxazone Torasemide may increase the excretion rate of Chlorzoxazone which could result in a lower serum level and potentially a reduction in efficacy.
Pyridoxine Pyridoxine Torasemide may increase the excretion rate of Pyridoxine which could result in a lower serum level and potentially a reduction in efficacy.
Folic Acid Folic Acid Torasemide may increase the excretion rate of Folic acid which could result in a lower serum level and potentially a reduction in efficacy.
Propranolol (Cardiovascular) Propranolol (Cardiovascular) Torasemide may increase the excretion rate of Propranolol which could result in a lower serum level and potentially a reduction in efficacy.
Minoxidil Minoxidil Torasemide may increase the hypotensive activities of Minoxidil.
Pseudoephedrine Pseudoephedrine Pseudoephedrine may decrease the antihypertensive activities of Torasemide.
Nortriptyline Nortriptyline Nortriptyline may decrease the antihypertensive activities of Torasemide.
Spironolactone Spironolactone The metabolism of Torasemide can be decreased when combined with Spironolactone.
Amphotericin B Injection Amphotericin B Injection The risk or severity of adverse effects can be increased when Amphotericin B is combined with Torasemide.
Phytonadione Phytonadione Torasemide may increase the excretion rate of Phylloquinone which could result in a lower serum level and potentially a reduction in efficacy.
Amikacin Injection Amikacin Injection The serum concentration of Amikacin can be increased when it is combined with Torasemide.
Nadolol Nadolol Torasemide may increase the excretion rate of Nadolol which could result in a lower serum level and potentially a reduction in efficacy.
Butorphanol Injection Butorphanol Injection The therapeutic efficacy of Torasemide can be decreased when used in combination with Butorphanol.
Nalbuphine Injection Nalbuphine Injection The therapeutic efficacy of Torasemide can be decreased when used in combination with Nalbuphine.
Cholestyramine Resin Cholestyramine Resin Cholestyramine can cause a decrease in the absorption of Torasemide resulting in a reduced serum concentration and potentially a decrease in efficacy.
Allopurinol Allopurinol The risk or severity of adverse effects can be increased when Torasemide is combined with Allopurinol.
Flavoxate Flavoxate Torasemide may increase the excretion rate of Flavoxate which could result in a lower serum level and potentially a reduction in efficacy.
Papaverine Papaverine The risk or severity of adverse effects can be increased when Papaverine is combined with Torasemide.
Fluorouracil Injection Fluorouracil Injection The metabolism of Fluorouracil can be decreased when combined with Torasemide.
Colchicine Colchicine The metabolism of Torasemide can be decreased when combined with Colchicine.
Cefaclor Cefaclor Torasemide may increase the excretion rate of Cefaclor which could result in a lower serum level and potentially a reduction in efficacy.
Cefadroxil Cefadroxil Torasemide may increase the excretion rate of Cefadroxil which could result in a lower serum level and potentially a reduction in efficacy.
Cephalexin Cephalexin Torasemide may increase the excretion rate of Cephalexin which could result in a lower serum level and potentially a reduction in efficacy.
Dacarbazine Dacarbazine Torasemide may increase the excretion rate of Dacarbazine which could result in a lower serum level and potentially a reduction in efficacy.
Nystatin Nystatin The excretion of Torasemide can be decreased when combined with Nystatin.
Calcitonin Salmon Injection Calcitonin Salmon Injection Torasemide may increase the excretion rate of Salmon calcitonin which could result in a lower serum level and potentially a reduction in efficacy.
Ketoconazole Ketoconazole The metabolism of Torasemide can be decreased when combined with Ketoconazole.
Pyrantel Pyrantel Torasemide may decrease the neuromuscular blocking activities of Pyrantel.
Vincristine Injection Vincristine Injection The excretion of Torasemide can be decreased when combined with Vincristine.
Captopril Captopril Torasemide may increase the hypotensive activities of Captopril.
Dipyridamole Dipyridamole Dipyridamole may increase the antihypertensive activities of Torasemide.
Isoxsuprine Isoxsuprine Isoxsuprine may decrease the antihypertensive activities of Torasemide.
Vinblastine Vinblastine The excretion of Torasemide can be decreased when combined with Vinblastine.
Ethacrynic Acid Ethacrynic Acid The risk or severity of ototoxicity can be increased when Etacrynic acid is combined with Torasemide.
Metoprolol Metoprolol Torasemide may increase the excretion rate of Metoprolol which could result in a lower serum level and potentially a reduction in efficacy.
Aspirin Aspirin Acetylsalicylic acid may decrease the excretion rate of Torasemide which could result in a higher serum level.
Salsalate Salsalate The therapeutic efficacy of Torasemide can be decreased when used in combination with Salsalate.
Alprazolam Alprazolam Torasemide may increase the excretion rate of Alprazolam which could result in a lower serum level and potentially a reduction in efficacy.
Temazepam Temazepam Torasemide may increase the excretion rate of Temazepam which could result in a lower serum level and potentially a reduction in efficacy.
Triazolam Triazolam Torasemide may increase the excretion rate of Triazolam which could result in a lower serum level and potentially a reduction in efficacy.
Dicyclomine Dicyclomine Torasemide may increase the excretion rate of Dicyclomine which could result in a lower serum level and potentially a reduction in efficacy.
Propantheline Propantheline Torasemide may increase the excretion rate of Propantheline which could result in a lower serum level and potentially a reduction in efficacy.
Trimethoprim Trimethoprim The metabolism of Trimethoprim can be decreased when combined with Torasemide.
Diltiazem Diltiazem The metabolism of Torasemide can be decreased when combined with Diltiazem.
Nifedipine Nifedipine The metabolism of Torasemide can be decreased when combined with Nifedipine.
Timolol Timolol Torasemide may increase the excretion rate of Timolol which could result in a lower serum level and potentially a reduction in efficacy.
Verapamil Verapamil The metabolism of Torasemide can be decreased when combined with Verapamil.
Atenolol Atenolol Torasemide may increase the hypotensive activities of Atenolol.
Pindolol Pindolol Torasemide may increase the excretion rate of Pindolol which could result in a lower serum level and potentially a reduction in efficacy.
Cisplatin Injection Cisplatin Injection The risk or severity of ototoxicity and nephrotoxicity can be increased when Torasemide is combined with Cisplatin.
Diflunisal Diflunisal The therapeutic efficacy of Torasemide can be decreased when used in combination with Diflunisal.
Piroxicam Piroxicam The therapeutic efficacy of Torasemide can be decreased when used in combination with Piroxicam.
Bumetanide Bumetanide Bumetanide may increase the excretion rate of Torasemide which could result in a lower serum level and potentially a reduction in efficacy.
Glipizide Glipizide The therapeutic efficacy of Glipizide can be increased when used in combination with Torasemide.
Indapamide Indapamide The therapeutic efficacy of Indapamide can be increased when used in combination with Torasemide.
Amoxicillin Amoxicillin Torasemide may increase the excretion rate of Amoxicillin which could result in a lower serum level and potentially a reduction in efficacy.
Oxacillin Injection Oxacillin Injection Torasemide may increase the excretion rate of Oxacillin which could result in a lower serum level and potentially a reduction in efficacy.
Pentoxifylline Pentoxifylline Pentoxifylline may increase the hypotensive activities of Torasemide.
Pentamidine Injection Pentamidine Injection The therapeutic efficacy of Pentamidine can be increased when used in combination with Torasemide.
Ceftriaxone Injection Ceftriaxone Injection Torasemide may increase the excretion rate of Ceftriaxone which could result in a lower serum level and potentially a reduction in efficacy.
Labetalol Labetalol Torasemide may increase the excretion rate of Labetalol which could result in a lower serum level and potentially a reduction in efficacy.
Auranofin Auranofin Torasemide may increase the excretion rate of Auranofin which could result in a lower serum level and potentially a reduction in efficacy.
Leuprolide Injection Leuprolide Injection Torasemide may increase the excretion rate of Leuprolide which could result in a lower serum level and potentially a reduction in efficacy.
Gemfibrozil Gemfibrozil The metabolism of Torasemide can be decreased when combined with Gemfibrozil.
Guanabenz Guanabenz Torasemide may decrease the antihypertensive activities of Guanabenz.
Ceftazidime Injection Ceftazidime Injection Torasemide may increase the excretion rate of Ceftazidime which could result in a lower serum level and potentially a reduction in efficacy.
Ketoprofen Ketoprofen The therapeutic efficacy of Torasemide can be decreased when used in combination with Ketoprofen.
Cefotetan Injection Cefotetan Injection Torasemide may increase the excretion rate of Cefotetan which could result in a lower serum level and potentially a reduction in efficacy.
Enalapril Enalapril Torasemide may increase the hypotensive activities of Enalapril.
Flurbiprofen Flurbiprofen The therapeutic efficacy of Torasemide can be decreased when used in combination with Flurbiprofen.
Amiodarone Amiodarone The metabolism of Amiodarone can be decreased when combined with Torasemide.
Aztreonam Injection Aztreonam Injection Torasemide may increase the excretion rate of Aztreonam which could result in a lower serum level and potentially a reduction in efficacy.
Buspirone Buspirone Torasemide may increase the excretion rate of Buspirone which could result in a lower serum level and potentially a reduction in efficacy.
Lovastatin Lovastatin The metabolism of Torasemide can be decreased when combined with Lovastatin.
Ciprofloxacin Ciprofloxacin Torasemide may increase the excretion rate of Ciprofloxacin which could result in a lower serum level and potentially a reduction in efficacy.
Mesalamine Mesalamine The therapeutic efficacy of Torasemide can be decreased when used in combination with Mesalazine.
Diclofenac Diclofenac The therapeutic efficacy of Torasemide can be decreased when used in combination with Diclofenac.
Fluoxetine Fluoxetine The metabolism of Torasemide can be decreased when combined with Fluoxetine.
Nimodipine Nimodipine Torasemide may increase the hypotensive activities of Nimodipine.
Clozapine Clozapine The metabolism of Clozapine can be decreased when combined with Torasemide.
Estazolam Estazolam Torasemide may increase the excretion rate of Estazolam which could result in a lower serum level and potentially a reduction in efficacy.
Idarubicin Idarubicin The metabolism of Idarubicin can be decreased when combined with Torasemide.
Didanosine Didanosine Torasemide may increase the excretion rate of Didanosine which could result in a lower serum level and potentially a reduction in efficacy.
Pentostatin Injection Pentostatin Injection Torasemide may increase the excretion rate of Pentostatin which could result in a lower serum level and potentially a reduction in efficacy.
Benazepril Benazepril Torasemide may increase the hypotensive activities of Benazepril.
Etodolac Etodolac The therapeutic efficacy of Torasemide can be decreased when used in combination with Etodolac.
Felodipine Felodipine The metabolism of Torasemide can be decreased when combined with Felodipine.
Fosinopril Fosinopril Torasemide may increase the excretion rate of Fosinopril which could result in a lower serum level and potentially a reduction in efficacy.
Nabumetone Nabumetone The therapeutic efficacy of Torasemide can be decreased when used in combination with Nabumetone.
Quinapril Quinapril Torasemide may increase the hypotensive activities of Quinapril.
Ramipril Ramipril Ramipril may increase the hypotensive activities of Torasemide.
Simvastatin Simvastatin The metabolism of Torasemide can be decreased when combined with Simvastatin.
Amlodipine Amlodipine Torasemide may increase the hypotensive activities of Amlodipine.
Teniposide Injection Teniposide Injection The metabolism of Torasemide can be decreased when combined with Teniposide.
Lisinopril Lisinopril Torasemide may increase the excretion rate of Lisinopril which could result in a lower serum level and potentially a reduction in efficacy.
Oxaprozin Oxaprozin The therapeutic efficacy of Torasemide can be decreased when used in combination with Oxaprozin.
Atovaquone Atovaquone The metabolism of Torasemide can be decreased when combined with Atovaquone.
Rifabutin Rifabutin The metabolism of Torasemide can be increased when combined with Rifabutin.
Sotalol Sotalol The risk or severity of adverse effects can be increased when Sotalol is combined with Torasemide.
Bisoprolol Bisoprolol Torasemide may increase the excretion rate of Bisoprolol which could result in a lower serum level and potentially a reduction in efficacy.
Zolpidem Zolpidem The metabolism of Zolpidem can be decreased when combined with Torasemide.
Doxazosin Doxazosin The metabolism of Doxazosin can be decreased when combined with Torasemide.
Terazosin Terazosin Torasemide may increase the hypotensive activities of Terazosin.
Isradipine Isradipine Torasemide may increase the excretion rate of Isradipine which could result in a lower serum level and potentially a reduction in efficacy.
Omeprazole Omeprazole The metabolism of Omeprazole can be decreased when combined with Torasemide.
Cisapride Cisapride The metabolism of Cisapride can be decreased when combined with Torasemide.
Fluvastatin Fluvastatin The metabolism of Torasemide can be decreased when combined with Fluvastatin.
Venlafaxine Venlafaxine The metabolism of Venlafaxine can be decreased when combined with Torasemide.
Fluvoxamine Fluvoxamine The metabolism of Torasemide can be decreased when combined with Fluvoxamine.
Nefazodone Nefazodone Torasemide may increase the excretion rate of Nefazodone which could result in a lower serum level and potentially a reduction in efficacy.
Lamotrigine Lamotrigine Torasemide may increase the excretion rate of Lamotrigine which could result in a lower serum level and potentially a reduction in efficacy.
Losartan Losartan The metabolism of Losartan can be decreased when combined with Torasemide.
Valacyclovir Valacyclovir Torasemide may increase the excretion rate of Valaciclovir which could result in a lower serum level and potentially a reduction in efficacy.
Tramadol Tramadol The therapeutic efficacy of Torasemide can be decreased when used in combination with Tramadol.
Carboplatin Injection Carboplatin Injection Torasemide may increase the excretion rate of Carboplatin which could result in a lower serum level and potentially a reduction in efficacy.
Moexipril Moexipril Torasemide may increase the hypotensive activities of Moexipril.
Lansoprazole Lansoprazole The metabolism of Lansoprazole can be decreased when combined with Torasemide.
Ifosfamide Injection Ifosfamide Injection The metabolism of Torasemide can be increased when combined with Ifosfamide.
Nicardipine Nicardipine The metabolism of Torasemide can be decreased when combined with Nicardipine.
Bupropion Bupropion The metabolism of Bupropion can be decreased when combined with Torasemide.
Ticlopidine Ticlopidine Ticlopidine may increase the excretion rate of Torasemide which could result in a lower serum level and potentially a reduction in efficacy.
Saquinavir Saquinavir The metabolism of Torasemide can be decreased when combined with Saquinavir.
Metformin Metformin The therapeutic efficacy of Metformin can be decreased when used in combination with Torasemide.
Nisoldipine Nisoldipine Torasemide may increase the excretion rate of Nisoldipine which could result in a lower serum level and potentially a reduction in efficacy.
Lamivudine Lamivudine Torasemide may increase the excretion rate of Lamivudine which could result in a lower serum level and potentially a reduction in efficacy.
Amifostine Injection Amifostine Injection Torasemide may increase the hypotensive activities of Amifostine.
Acarbose Acarbose The therapeutic efficacy of Acarbose can be increased when used in combination with Torasemide.
Glimepiride Glimepiride The therapeutic efficacy of Glimepiride can be increased when used in combination with Torasemide.
Anastrozole Anastrozole The metabolism of Torasemide can be decreased when combined with Anastrozole.
Gemcitabine Injection Gemcitabine Injection Torasemide may increase the excretion rate of Gemcitabine which could result in a lower serum level and potentially a reduction in efficacy.
Indinavir Indinavir The excretion of Torasemide can be decreased when combined with Indinavir.
Ritonavir Ritonavir The metabolism of Torasemide can be decreased when combined with Ritonavir.
Cidofovir Injection Cidofovir Injection Torasemide may increase the excretion rate of Cidofovir which could result in a lower serum level and potentially a reduction in efficacy.
Meropenem Injection Meropenem Injection Torasemide may increase the excretion rate of Meropenem which could result in a lower serum level and potentially a reduction in efficacy.
Clomipramine Clomipramine Clomipramine may increase the excretion rate of Torasemide which could result in a lower serum level and potentially a reduction in efficacy.
Zafirlukast Zafirlukast The metabolism of Torasemide can be decreased when combined with Zafirlukast.
Fosfomycin Fosfomycin Torasemide may increase the excretion rate of Fosfomycin which could result in a lower serum level and potentially a reduction in efficacy.
Mirtazapine Mirtazapine Mirtazapine may decrease the antihypertensive activities of Torasemide.
Trandolapril Trandolapril Torasemide may increase the hypotensive activities of Trandolapril.
Topiramate Topiramate The risk or severity of hypokalemia can be increased when Torasemide is combined with Topiramate.
Zileuton Zileuton The metabolism of Zileuton can be decreased when combined with Torasemide.
Valsartan Valsartan The metabolism of Torasemide can be decreased when combined with Valsartan.
Insulin Lispro Injection Insulin Lispro Injection The therapeutic efficacy of Insulin lispro can be increased when used in combination with Torasemide.
Pramipexole Pramipexole Pramipexole may increase the excretion rate of Torasemide which could result in a lower serum level and potentially a reduction in efficacy.
Donepezil Donepezil The metabolism of Donepezil can be decreased when combined with Torasemide.
Nelfinavir Nelfinavir The metabolism of Torasemide can be decreased when combined with Nelfinavir.
Loratadine Loratadine The metabolism of Torasemide can be decreased when combined with Loratadine.
Nilutamide Nilutamide The metabolism of Torasemide can be decreased when combined with Nilutamide.
Flutamide Flutamide Torasemide may increase the excretion rate of Flutamide which could result in a lower serum level and potentially a reduction in efficacy.
Selegiline Selegiline Selegiline may increase the hypotensive activities of Torasemide.
Bicalutamide Bicalutamide The metabolism of Torasemide can be decreased when combined with Bicalutamide.
Sertraline Sertraline The metabolism of Sertraline can be decreased when combined with Torasemide.
Propafenone Propafenone Propafenone may decrease the antihypertensive activities of Torasemide.
Raloxifene Raloxifene The metabolism of Torasemide can be decreased when combined with Raloxifene.
Irbesartan Irbesartan The metabolism of Torasemide can be decreased when combined with Irbesartan.
Tamsulosin Tamsulosin Tamsulosin may increase the excretion rate of Torasemide which could result in a lower serum level and potentially a reduction in efficacy.
Ropinirole Ropinirole The risk or severity of adverse effects can be increased when Ropinirole is combined with Torasemide.
Finasteride Finasteride Finasteride may decrease the antihypertensive activities of Torasemide.
Quetiapine Quetiapine Quetiapine may increase the hypotensive activities of Torasemide.
Cetirizine Cetirizine Torasemide may increase the excretion rate of Cetirizine which could result in a lower serum level and potentially a reduction in efficacy.
Paroxetine Paroxetine The metabolism of Paroxetine can be decreased when combined with Torasemide.
Tolcapone Tolcapone The metabolism of Torasemide can be decreased when combined with Tolcapone.
Capecitabine Capecitabine The metabolism of Torasemide can be decreased when combined with Capecitabine.
Efavirenz Efavirenz The metabolism of Torasemide can be decreased when combined with Efavirenz.
Abacavir Abacavir Torasemide may increase the excretion rate of Abacavir which could result in a lower serum level and potentially a reduction in efficacy.
Sildenafil Sildenafil The metabolism of Torasemide can be decreased when combined with Sildenafil.
Pioglitazone Pioglitazone The metabolism of Torasemide can be decreased when combined with Pioglitazone.
Celecoxib Celecoxib The therapeutic efficacy of Torasemide can be decreased when used in combination with Celecoxib.
Rosiglitazone Rosiglitazone The metabolism of Torasemide can be decreased when combined with Rosiglitazone.
Tolterodine Tolterodine The metabolism of Tolterodine can be decreased when combined with Torasemide.
Thalidomide Thalidomide The metabolism of Thalidomide can be decreased when combined with Torasemide.
Oseltamivir Oseltamivir Torasemide may increase the excretion rate of Oseltamivir which could result in a lower serum level and potentially a reduction in efficacy.
Colesevelam Colesevelam Colesevelam can cause a decrease in the absorption of Torasemide resulting in a reduced serum concentration and potentially a decrease in efficacy.
Balsalazide Balsalazide The therapeutic efficacy of Torasemide can be decreased when used in combination with Balsalazide.
Nateglinide Nateglinide The therapeutic efficacy of Nateglinide can be increased when used in combination with Torasemide.
Rabeprazole Rabeprazole The metabolism of Torasemide can be decreased when combined with Rabeprazole.
Terbinafine Terbinafine The metabolism of Terbinafine can be decreased when combined with Torasemide.

Content provided by: AHFS® Patient Medication Information™. © Copyright, 2021. The American Society of Health-System Pharmacists